{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01263717","recordId":"NCT01263717","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01263717-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01263717.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01263717.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2010-12-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2010-12-20","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"2b41403d6278e5a010b9a5b59b24b3e3b349fc37d31e10ea6380e011f6be074a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2011-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2011-04-15","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"a61a8728ceb4711d5a6f22b583b513fd4fa3a9003b0e79e0f7cad661f8e0aa43","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2011-10-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2011-10-05","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"12a4e4e036ace843520fe47cb7113476a4e9d7adf693ffdaa3b3340e1e3b55d9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2012-04-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2012-04-18","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"51580889575ff5893c6148419ce53dfa9338a929ce5048d5dc6521dd1190329a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2012-11-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2012-11-09","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"ef382093d098153dbee9344f8e49a4ec4b7db1501b66e2e82c8726d949336b75","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2013-03-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2013-03-12","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"c6cb29561e47d1351e8be4a4a5e6ce7c2384fe71dd4dad5fc4ffbe9dae5f197e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2013-08-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2013-08-27","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"68f1fc3349bffb82fd0ad5d8031e4cb855283aa3b2f5bf6ff8e4072b25b14bbd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2014-05-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2014-05-02","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"68474d0ae059831658885b85e1daf3be404ed7991e247cdc2d65c2ba6cd0e639","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Contacts/Locations","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","References","Study Design","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2014-10-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2014-10-10","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"91dda507d28b15877972684ae00a251797e09cd2bb8d0447661d69f592c3c7de","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Limitations and Caveats","Outcome Measures (Results)","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2017-09-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2017-09-28","publishedAt":"2026-08-23","recordId":"NCT01263717","recordSha256":"81f11902464f8176f00608d889b2378edbf3d351cc875f02532fea2df69c9e6e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01263717?a=10&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"70e9eac16e66343e40cca5b150e383668a9851fc20b54052e6bd9fa1be7b0dd2"}}